Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting

Subcutaneous phycomycosis becomes a chronic, debilitating condition if left untreated. Treatment includes oral antifungal therapy, though oral potassium iodide has been used in resource-limited settings. Lugol's iodine has been an effective substitute, but little is known about its safety. We r...

Full description

Bibliographic Details
Main Authors: Dean S. Karahalios, Andrea Shaw, Bonnke Arunga, Carlee Lenehan, Valentine Sing'oei, Walter Otieno
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Medical Mycology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221175392200032X
_version_ 1811295695775203328
author Dean S. Karahalios
Andrea Shaw
Bonnke Arunga
Carlee Lenehan
Valentine Sing'oei
Walter Otieno
author_facet Dean S. Karahalios
Andrea Shaw
Bonnke Arunga
Carlee Lenehan
Valentine Sing'oei
Walter Otieno
author_sort Dean S. Karahalios
collection DOAJ
description Subcutaneous phycomycosis becomes a chronic, debilitating condition if left untreated. Treatment includes oral antifungal therapy, though oral potassium iodide has been used in resource-limited settings. Lugol's iodine has been an effective substitute, but little is known about its safety. We report a case of subcutaneous phycomycosis complicated by heart failure during treatment with Lugol's iodine. We review subcutaneous phycomycosis, iodine-mediated cardiotoxicity, as well as social determinants of health relevant to our case, suggesting that Lugol's iodine may only be an effective treatment with proper dosing and long-term monitoring.
first_indexed 2024-04-13T05:36:25Z
format Article
id doaj.art-2403ffbaba8745f7ab3ad61699256c96
institution Directory Open Access Journal
issn 2211-7539
language English
last_indexed 2024-04-13T05:36:25Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Medical Mycology Case Reports
spelling doaj.art-2403ffbaba8745f7ab3ad61699256c962022-12-22T03:00:15ZengElsevierMedical Mycology Case Reports2211-75392022-12-0138912Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited settingDean S. Karahalios0Andrea Shaw1Bonnke Arunga2Carlee Lenehan3Valentine Sing'oei4Walter Otieno5SUNY Upstate Medical University Department of Pediatrics, 750 East Adams Street, Syracuse, NY, 13210, USA; Corresponding author. Children's Hospital of Michigan Department of Pediatrics, Division of Pediatric Cardiology, 3901, Beaubien Boulevard, Detroit, MI, 48201, United States.SUNY Upstate Medical University Departments of Medicine, Pediatrics, and International Health, 750 East Adams Street, Syracuse, NY, 13210, USAObama Children's Hospital, Jomo Kenyatta Highway Kaloleni, Kisumu, KenyaSUNY Upstate Medical University Department of Pediatrics, 750 East Adams Street, Syracuse, NY, 13210, USAObama Children's Hospital, Jomo Kenyatta Highway Kaloleni, Kisumu, KenyaObama Children's Hospital, Jomo Kenyatta Highway Kaloleni, Kisumu, KenyaSubcutaneous phycomycosis becomes a chronic, debilitating condition if left untreated. Treatment includes oral antifungal therapy, though oral potassium iodide has been used in resource-limited settings. Lugol's iodine has been an effective substitute, but little is known about its safety. We report a case of subcutaneous phycomycosis complicated by heart failure during treatment with Lugol's iodine. We review subcutaneous phycomycosis, iodine-mediated cardiotoxicity, as well as social determinants of health relevant to our case, suggesting that Lugol's iodine may only be an effective treatment with proper dosing and long-term monitoring.http://www.sciencedirect.com/science/article/pii/S221175392200032XSubcutaneous phycomycosisFungal infectionLugol's iodineHeart failureSocial determinants of health
spellingShingle Dean S. Karahalios
Andrea Shaw
Bonnke Arunga
Carlee Lenehan
Valentine Sing'oei
Walter Otieno
Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting
Medical Mycology Case Reports
Subcutaneous phycomycosis
Fungal infection
Lugol's iodine
Heart failure
Social determinants of health
title Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting
title_full Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting
title_fullStr Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting
title_full_unstemmed Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting
title_short Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting
title_sort adverse effects of lugol s iodine heart failure in a patient with subcutaneous phycomycosis from a resource limited setting
topic Subcutaneous phycomycosis
Fungal infection
Lugol's iodine
Heart failure
Social determinants of health
url http://www.sciencedirect.com/science/article/pii/S221175392200032X
work_keys_str_mv AT deanskarahalios adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting
AT andreashaw adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting
AT bonnkearunga adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting
AT carleelenehan adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting
AT valentinesingoei adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting
AT walterotieno adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting